We actively communicate on our business, services and technical capabilities. Use the resources on this page to browse through recent news, to subscribe to our news services or to meet us at one of our forthcoming events.
16 Feb 2021 - PolyPeptide Group, a global leader in peptide manufacturing and development, today announced the appointment of as its new Chief Executive Officer. He will succeed Jane Salik […]
Read more28 Jan 2021 - Get to know Christelle Bobier, Director Global Engineering and Manufacturing Technology, in our newsletter. PolyPeptide Group maintained a strong and healthy pipeline that has gained a […]
Read more28 Jan 2021 - PolyPeptide Group is proud to report double-digit growth for its pipeline projects. PolyPeptide Group maintained a strong and healthy pipeline that has gained a significant growth […]
Read more8 Dec 2020 - The Polypeptide Group has developed a set of tools using Ypso-Proxima® software. They help make the most efficient choices at an early stage. The field of […]
Read more17 Sep 2020 - The PolyPeptide Group is working on projects with clients developing peptide-based therapies and vaccines to combat COVID-19. As a Global Leader in Peptide Manufacturing and Development, […]
Read more17 Sep 2020 - We have made considerable investments in scale capacities to satisfy the needs of our customers from early stage development to commercial production. Considering the continuous growth […]
Read more15 Jun 2020 - Aiming at advancing protocols for safer, environmentally sensible peptide synthesis we report our findings with regard to the occurrence of hydrogen cyanide (HCN, prussic acid) in amide bond-forming reactions mediated by diisopropylcarbodiimide (DIC) and ethyl (hydroxyimino)cyanoacetate (Oxyma).[…]
Read more4 Jun 2020 - The PolyPeptide Group, a global Contract Development and Manufacturing Organization (CDMO) for Peptide, Peptidomimetic and other Drug Substances, has announced that it has partnered with Novavax […]
Read more12 May 2020 - While the COVID-19 crisis continues, the PolyPeptide Group is actively engaged in helping find treatments and vaccines for COVID-19. While the COVID-19 crisis continues, the PolyPeptide […]
Read more